Talmadge JE - Search Results

1

Pharmacodynamic aspects of peptide administration biological response modifiers.

Talmadge JE. Talmadge JE. Adv Drug Deliv Rev. 1998 Sep 7;33(3):241-252. doi: 10.1016/s0169-409x(98)00032-5. Adv Drug Deliv Rev. 1998. PMID: 10837664

2

Interleukin-12 enhances peripheral hematopoiesis in vivo.

Jackson JD, Yan Y, Brunda MJ, Kelsey LS, Talmadge JE. Jackson JD, et al. Among authors: talmadge je. Blood. 1995 May 1;85(9):2371-6. Blood. 1995. PMID: 7727771

3

Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products.

Singh RK, Ino K, Varney ML, Heimann DG, Talmadge JE. Singh RK, et al. Among authors: talmadge je. Bone Marrow Transplant. 1999 Jan;23(1):53-62. doi: 10.1038/sj.bmt.1701518. Bone Marrow Transplant. 1999. PMID: 10037051

4

Synergy in the toxicity of cytokines: preclinical studies.

Talmadge JE. Talmadge JE. Int J Immunopharmacol. 1992 Apr;14(3):383-90. doi: 10.1016/0192-0561(92)90168-k. Int J Immunopharmacol. 1992. PMID: 1618592 Review.

5

Purging of human breast cancer cells from stem cell products with an adenovirus containing p53.

Hirai M, Kelsey LS, Vaillancourt M, Maneval DC, Watanabe T, Talmadge JE. Hirai M, et al. Among authors: talmadge je. Cancer Gene Ther. 2000 Feb;7(2):197-206. doi: 10.1038/sj.cgt.7700088. Cancer Gene Ther. 2000. PMID: 10770627

6

Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice.

Robinson SN, Chavez JM, Pisarev VM, Mosley RL, Rosenthal GJ, Blonder JM, Talmadge JE. Robinson SN, et al. Among authors: talmadge je. Bone Marrow Transplant. 2003 Mar;31(5):361-9. doi: 10.1038/sj.bmt.1703816. Bone Marrow Transplant. 2003. PMID: 12634727

7

Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients.

Singh RK, Varney ML, Ino K, Vose JM, Bierman PJ, Talmadge JE. Singh RK, et al. Among authors: talmadge je. Exp Hematol. 2000 May;28(5):499-507. doi: 10.1016/s0301-472x(00)00145-4. Exp Hematol. 2000. PMID: 10812239

8

Expression of interleukin-10 in isolated CD8+ T cells and monocytes from growth factor-mobilized peripheral blood stem cell products: a mechanism of immune dysfunction.

Varney ML, Ino K, Ageitos AG, Heimann DG, Talmadge JE, Singh RK. Varney ML, et al. Among authors: talmadge je. J Interferon Cytokine Res. 1999 Apr;19(4):351-60. doi: 10.1089/107999099314054. J Interferon Cytokine Res. 1999. PMID: 10334386

9

Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.

Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, Varney M, Jackson J, Vose JM, Bierman PJ. Talmadge JE, et al. Bone Marrow Transplant. 1997 Jan;19(2):161-72. doi: 10.1038/sj.bmt.1700626. Bone Marrow Transplant. 1997. PMID: 9116614 Clinical Trial.

10

Development of immunotherapeutic strategies for the treatment of malignant neoplasms.

Talmadge JE. Talmadge JE. Biotherapy. 1992;4(3):215-36. doi: 10.1007/BF02174208. Biotherapy. 1992. PMID: 1599805 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results